Intra-amniotic administration of prostaglandin F 2   to induce therapeutic abortion. Efficacy and tolerance of two dosage schedules.
D000032:Abortion, Therapeutic; D000653:Amniotic Fluid; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006982:Hypertonic Solutions; D007958:Leukocyte Count; D008214:Lymphocytes; D009504:Neutrophils; D010146:Pain / Q000453:epidemiology; D010298:Parity; D011247:Pregnancy; D011292:Premedication; D011346:Prochlorperazine / Q000627:therapeutic use; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects; D012965:Sodium Chloride / Q000008:administration & dosage; D013997:Time Factors; D014839:Vomiting / Q000453:epidemiology / Q000517:prevention & control
D006982:Hypertonic Solutions; D011453:Prostaglandins; D012965:Sodium Chloride; D011346:Prochlorperazine